Adoption of rotavirus vaccine by U.S. physicians: progress and challenges.

ABSTRACT:

Background

Pentavalent rotavirus vaccine (RV5) was recommended for routine use in 2006 followed by monovalent rotavirus vaccine (RV1) in 2008.

Purpose

To describe, among a U.S. sample of pediatricians (n=289 respondents) and family medicine physicians (n=243 respondents), (1) current practices regarding rotavirus vaccine (RV) and barriers to use with comparison to a 2007 survey and (2) knowledge of recent safety concerns regarding RV1 and their impact on its use.

Methods

A mail and Internet survey was conducted with the physicians, from November 2010 to January 2011; analyses were conducted March-September 2011.

Results

Response rates were 70% (289/410) for pediatricians and 61% (243/401) for family medicine physicians; routine administration of RV was reported

SUBMITTER: O'Leary ST 

PROVIDER: S-EPMC5846097 | biostudies-literature | 2013 Jan

REPOSITORIES: biostudies-literature